UNSPSC 51372042: Thebacon hydrochloride

This classification denotes an opioid receptor agonist C20H23NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Y58V95HC, chemically known as .delta.6-codeine, acetate, hydrochloride, but more generally known as thebacon hydrochloride, which bears US NIH Compound Identifier 12443397. European Medicines Agency schedules Thebacon hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04769MIG.

Most nations, for tariff and trade purposes, schedule thebacon hydrochloride under HS 29391100 and SITC 54141. As of Q4 2014, THEBACON HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(=O)OC1=CC[C@H]2[C@H]3CC4CCC(C5C4[C@]2([C@H]1O5)CCN3C)OC.CL.

UNSPSC 51372042 Theobacon hydrochloride is a Commodity code that does not align with recent state and local procurement activity. The three most recent opportunities tagged under this code—Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's direct-to-manufacturer prescription program RFI, and MMCAP's multi-source generic pharmaceuticals and OTC products RFP—cover naloxone, prescription fulfillment infrastructure, and broad generic pharmaceutical and over-the-counter product categories. None of these solicitations specifically reference theobacon hydrochloride or related branded or generic theobaine-derivative products. The code shows no relevant recent state and local activity.

The mismatch suggests either a tagging error in the source data or that theobacon hydrochloride, as a specific pharmaceutical ingredient or finished-dose product, does not generate standalone state and local procurement demand under this code at present. State and local buyers sourcing controlled-substance pharmaceuticals typically do so through cooperative purchasing vehicles (such as MMCAP), authorized wholesaler networks, or multi-source generic frameworks rather than direct manufacturer procurement of individual active pharmaceutical ingredients. Firms pursuing opportunities in pharmaceutical and OTC product supply to state and local health and human services agencies should monitor broader family-level codes covering generic pharmaceuticals, naloxone distribution, and health department supplies rather than this narrowly defined commodity code.